SEC Filings TLDR

LATAM Airlines Group S.A. has announced a significant capital reduction following the cancellation of 30,221,893,878 shares acquired under share repurchase programs. This reduction decreases the company's capital from US$5,003,576,326.78 to US$4,418,152,114.78, with the number of shares reduced from 604,441,789,335 to ...

Kingsoft Cloud Holdings Limited announced the grant of 16,205,511 Restricted Share Units (RSUs) to 352 employees on October 16, 2025, under the 2021 Share Incentive Plan. The RSUs represent approximately 0.36% of the total issued shares of the company. The RSUs will vest in batches over a period of one to three years, ...

On October 16, 2025, Mr. Shu Liu resigned as a director and the chair of the Audit Committee of Jiuzi Holdings Inc. His resignation was not due to any disagreement with the company. On the same day, Mr. Pengyuan Li was elected as a director to fill the vacancy left by Mr. Liu. Mr. Li will also serve as the chair of the...

James Hardie Industries plc filed a Form 6-K with the SEC for October 2025. The filing includes forward-looking statements regarding the company's future performance, acquisition of AZEK, and other strategic initiatives. It also details the issuance of unquoted securities and updates on substantial holdings. The filing...

Immuron Limited has announced a proposed issue of securities on October 17, 2025. The company plans to issue 1,133,840 ordinary fully paid shares at a price of AUD 0.08860 per share. The issuance is intended to further research and development activities and provide ongoing working capital. The shares will rank equally...

IceCure Medical Ltd. announced the termination of Ms. Galit Malik, the Vice President of Operations and Services, effective January 15, 2026. The termination was not due to any disagreement with the company regarding its operations, policies, or practices. This information was reported in a Form 6-K filed with the Secu...

InterContinental Hotels Group PLC (IHG) reported a series of share repurchases conducted between October 3 and October 16, 2025. The repurchases were executed on the London Stock Exchange through Merrill Lynch International, in accordance with the authority granted by shareholders at the Annual General Meeting on May 8...

On October 13, 2025, Haoxi Health Technology Limited entered into a securities purchase agreement with certain non-U.S. persons to sell 5,217,391 Class A ordinary shares at a price of $0.23 per share, raising approximately $1.2 million. The net proceeds will be used for working capital and general corporate purposes. T...

HSBC Holdings plc has announced the purchase of its own shares for cancellation as part of its buy-back program initiated on 31 July 2025. On 17 October 2025, the company repurchased 4,942,855 ordinary shares on UK Venues at a volume-weighted average price of £9.7082 per share and 4,566,400 ordinary shares on the Hong ...

Global Ship Lease, Inc. (GSL) issued a statement in response to the Implementation Measures on the Special Port Charges for U.S. Vessels issued by the Ministry of Transport of China. GSL clarified that it is a corporation formed under the laws of the Republic of the Marshall Islands, with its principal executive office...

GeoPark Limited announced the completion of its acquisition from Pluspetrol S.A. of a 100% operated working interest in the Loma Jarillosa Este and Puesto Silva Oeste blocks in the Vaca Muerta formation, Argentina. The acquisition, totaling $115 million, includes all required governmental and regulatory approvals. GeoP...

GSK plc, acting through BNP Paribas SA, purchased 310,000 of its ordinary shares on 16 October 2025 as part of its existing buyback programme. The shares were bought at prices ranging from 1,621.50p to 1,637.00p, with a volume-weighted average price of 1,629.84p. The purchased shares will be held as treasury shares. Fo...

GH Research PLC announced the acceptance of three clinical trial posters at the ACNP annual meeting. The posters detail positive results from Phase 2b trials of GH001 (synthetic mebufotenin) in treatment-resistant depression (TRD) and a Phase 2a trial in bipolar II disorder. Key findings include rapid and sustained ant...

Genmab A/S reported worldwide net trade sales of DARZALEX (daratumumab) for the third quarter of 2025, totaling USD 3,672 million. This includes sales of the subcutaneous product, DARZALEX FASPRO. The U.S. contributed USD 2,088 million, while the rest of the world accounted for USD 1,584 million. Genmab receives royalt...

Fury Gold Mines Limited has filed a technical report for the Eau Claire Gold Project in Quebec, titled 'Technical Report – Preliminary Economic Assessment of the Eau Claire Project, Eeyou Istchee James Bay Region of Quebec, Canada.' The report, with an effective date of August 25, 2025, was prepared in accordance with ...

Fury Gold Mines Limited announced the completion of a brokered private placement on October 14, 2025. The company issued 9,915,000 flow-through units at $1.21 per unit and 6,003,000 flow-through shares at $1.00 per share, raising a total of $18,000,150. The flow-through units consist of one common share and one-half of...

FBS Global Limited, a Singapore-based green building contractor, reported its unaudited financial results for the six months ended June 30, 2025. The company experienced a 5.9% decrease in revenue, amounting to S$7.8 million (US$6.0 million), primarily due to fewer progress claims as several projects were in their init...

Evaxion A/S, a Danish biotechnology company, reported a capital increase through the sale of 1,018,000 American Depositary Shares (ADSs) at an average price of USD $4.3931 per ADS, resulting in total proceeds of approximately $4.3 million. The company also amended its Articles of Association to reflect this capital inc...

Evaxion A/S announced a 75% Objective Response Rate (ORR) in its Phase 2 trial for the AI-designed personalized cancer vaccine EVX-01. The trial involved 16 advanced melanoma patients, with 12 showing objective clinical responses, including 11 continuing to respond at 24 months follow-up. The vaccine, developed using E...

Erayak Power Solution Group Inc. announced the establishment of its U.S. subsidiary, Nexora Group Inc., as part of its global expansion strategy. The subsidiary will serve as the regional headquarters in North America, enhancing sales, marketing, and logistics capabilities while fostering localized product customizatio...

Eshallgo Inc. has entered into a letter agreement to amend the floor price of its convertible debenture to $0.40 per share. The convertible debenture, originally issued on November 29, 2024, had an aggregate principal amount of $5,000,000. The amendment, effective as of October 17, 2025, was made pursuant to a securiti...

On October 15, 2025, ESHALLGO INC adopted the 2025 Equity Incentive Plan (the "2025 Plan") to motivate, attract, and retain directors, consultants, and key employees. The 2025 Plan aims to align the interests of these individuals with those of the company's shareholders by offering equity incentives. The plan allows fo...

Equinor ASA has announced details of its share buy-back program, which is part of its share-based incentive programs for employees and management. The program, announced on February 5, 2025, will run from February 14, 2025, to January 15, 2026, with a total purchase amount of NOK 1,992,000,000. The maximum number of sh...

Endeavour Silver Corp. announced on October 16, 2025, that it has achieved commercial production at its Terronera mine in Jalisco state, Mexico, effective October 1, 2025. The declaration followed a successful commissioning phase where mining and processing operations consistently exceeded 90% of the designed nameplate...

Diversified Energy Company PLC has filed a Form 6-K with the SEC, proposing a reorganization that will establish a new US holding company, Diversified Energy Company (NewCo), as the parent company of the Group. The reorganization will be implemented through a UK Court-sanctioned Scheme of Arrangement. If approved, shar...